Old Web
English
Sign In
Acemap
>
authorDetail
>
Cheryl Beachler
Cheryl Beachler
Pennsylvania State University
Medicine
Internal medicine
Oncology
FOLFIRI
Fluorouracil
3
Papers
53
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Personalized dosing via pharmacokinetic monitoring of 5-fluorouracil might reduce toxicity in early- or late-stage colorectal cancer patients treated with infusional 5-fluorouracil-based chemotherapy regimens.
2014
Clinical Colorectal Cancer
Christina Leah B. Kline
Angelique Schiccitano
Junjia Zhu
Cheryl Beachler
Hassan Sheikh
Harold A. Harvey
Heath B. Mackley
Kevin McKenna
Kevin F. Staveley-O'Carroll
Lisa S. Poritz
Evangelos Messaris
David B. Stewart
Jeffrey Sivik
Wafik S. El-Deiry
Show All
Source
Cite
Save
Citations (25)
FOLFIRI plus dulanermin (rhApo2L/TRAIL) in a patient with BRAF-mutant metastatic colon cancer
2013
Cancer Biology & Therapy
Bora Lim
Angelique Scicchitano
Cheryl Beachler
Niraj J. Gusani
Nabeel Sarwani
Zhaohai Yang
Kevin F. Staveley-O'Carroll
Avi Ashkenazi
Chia C. Portera
Wafik S. El-Deiry
Show All
Source
Cite
Save
Citations (10)
Preliminary observations indicate variable patterns of plasma 5-fluorouracil (5-FU) levels during dose optimization of infusional 5-FU in colorectal cancer patients
2011
Cancer Biology & Therapy
Christina Leah B. Kline
Hassan Sheikh
Angelique Scicchitano
Rebecca Gingrich
Cheryl Beachler
Niklas Finnberg
Jason Liao
Jeffrey Sivik
Wafik S. El-Deiry
Show All
Source
Cite
Save
Citations (18)
1